FR2514350B1 - N-(4- (3-aminopropyl) aminobutyl)-2-(o-guanidino (acide gras)amido)-ethanamides substitues en position 2 et leurs sels, procede pour leur preparation et leur application therapeutique - Google Patents

N-(4- (3-aminopropyl) aminobutyl)-2-(o-guanidino (acide gras)amido)-ethanamides substitues en position 2 et leurs sels, procede pour leur preparation et leur application therapeutique

Info

Publication number
FR2514350B1
FR2514350B1 FR8216894A FR8216894A FR2514350B1 FR 2514350 B1 FR2514350 B1 FR 2514350B1 FR 8216894 A FR8216894 A FR 8216894A FR 8216894 A FR8216894 A FR 8216894A FR 2514350 B1 FR2514350 B1 FR 2514350B1
Authority
FR
France
Prior art keywords
ethanamides
aminobutyl
guanidino
aminopropyl
amido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8216894A
Other languages
English (en)
French (fr)
Other versions
FR2514350A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of FR2514350A1 publication Critical patent/FR2514350A1/fr
Application granted granted Critical
Publication of FR2514350B1 publication Critical patent/FR2514350B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8216894A 1981-10-08 1982-10-08 N-(4- (3-aminopropyl) aminobutyl)-2-(o-guanidino (acide gras)amido)-ethanamides substitues en position 2 et leurs sels, procede pour leur preparation et leur application therapeutique Expired FR2514350B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56159503A JPS5862152A (ja) 1981-10-08 1981-10-08 Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法

Publications (2)

Publication Number Publication Date
FR2514350A1 FR2514350A1 (fr) 1983-04-15
FR2514350B1 true FR2514350B1 (fr) 1985-10-25

Family

ID=15695187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8216894A Expired FR2514350B1 (fr) 1981-10-08 1982-10-08 N-(4- (3-aminopropyl) aminobutyl)-2-(o-guanidino (acide gras)amido)-ethanamides substitues en position 2 et leurs sels, procede pour leur preparation et leur application therapeutique

Country Status (19)

Country Link
US (3) US4518532A (enExample)
JP (1) JPS5862152A (enExample)
KR (1) KR870000656B1 (enExample)
AT (1) AT393680B (enExample)
AU (1) AU554489B2 (enExample)
BE (1) BE894651A (enExample)
CA (1) CA1187513A (enExample)
CH (1) CH653015A5 (enExample)
CS (1) CS268654B2 (enExample)
DE (1) DE3236725A1 (enExample)
DK (1) DK166080C (enExample)
ES (2) ES516258A0 (enExample)
FR (1) FR2514350B1 (enExample)
GB (1) GB2111480B (enExample)
HU (1) HU187417B (enExample)
IT (1) IT1189373B (enExample)
NL (1) NL193107C (enExample)
SE (1) SE452006B (enExample)
YU (1) YU44678B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862152A (ja) * 1981-10-08 1983-04-13 Microbial Chem Res Found Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法
JPS60181056A (ja) * 1984-02-29 1985-09-14 Takara Shuzo Co Ltd Ν−〔４−（３−アミノプロピル）アミノブチル〕−２，２−ジヒドロキシエタンアミドの製造法
JPS60185758A (ja) * 1984-03-02 1985-09-21 Microbial Chem Res Found フエニレン基を有するスパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
JPH0742268B2 (ja) * 1985-08-27 1995-05-10 財団法人微生物化学研究会 フエニレン基を有するスパガリン類縁化合物及びその製造法
EP0241797B1 (en) * 1986-04-04 1991-06-12 Microbial Chemistry Research Foundation Novel spergualin-related compounds and process for producing the same
JP2605762B2 (ja) * 1986-12-10 1997-04-30 武田薬品工業株式会社 δ−ハイドロキシ−β−リジン誘導体およびその製造法
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions
JPH0776204B2 (ja) * 1988-07-01 1995-08-16 寳酒造株式会社 スパガリン類の精製法
US4990536A (en) * 1989-04-03 1991-02-05 Nippon Kayaku Kabushiki Kaisha Immunopotentiator and spergualin-related compound therefor
YU48230B (sh) * 1989-05-29 1997-08-22 Takara Shuzo Co.Ltd. Kristalni deoksispergvalin i postupak za njegovo pripremanje
US5162581A (en) * 1989-05-29 1992-11-10 Takaru Shuzo Co., Ltd. Crystalline deoxyspergualin, process for its preparation and suppository containing the same
US5196453A (en) * 1989-05-29 1993-03-23 Takara Shuzo Co., Ltd. Crystalline deoxyspergualin, process for its preparation and suppository containing the same
RU2171811C2 (ru) * 1989-05-29 2001-08-10 Такара Сузо Ко., Лтд., (Jp), Ниппон Каяку Кабусики Кайся КРИСТАЛЛИЧЕСКИЙ ТРИГИДРОХЛОРИД ДЕОКСИСПЕРГУАЛИНА В β-ФОРМЕ, ОБЛАДАЮЩИЙ ПРОТИВООПУХОЛЕВОЙ АКТИВНОСТЬЮ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
DE69104291T2 (de) * 1990-07-20 1995-05-18 Nippon Kayaku Kk Spergulinähnliche Verbindungen und ihre Verwendung.
WO1994004140A1 (fr) * 1992-08-19 1994-03-03 Nippon Kayaku Kabushiki Kaisha Medicament anti-protozoose
CA2183917A1 (en) * 1995-09-26 1997-03-27 Xuebao Wang Preparation of optically active (s)-(-) and (r)-(+)- deoxyspergualin and novel intermediates thereof
WO1999047128A1 (en) 1998-03-19 1999-09-23 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
US6656917B1 (en) * 1999-06-30 2003-12-02 Marker Gene Technologies, Inc. Compositions and methods for targeted enzymatic release of cell regulatory compounds
US8716558B2 (en) 1999-06-30 2014-05-06 Marker Gene Technologies, Inc. Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase
AU2003280437A1 (en) * 2002-06-27 2004-01-19 Microport Medical (Shanghai) Co., Ltd. Drug eluting stent
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
RU2596787C2 (ru) 2010-07-09 2016-09-10 БиЭйчВи ФАРМА, ИНК. Комбинированная система доставки с немедленным/замедленным высвобождением для лекарственных средств с коротким периодом полувыведения, в том числе для ремоглифлозина
HUE058834T2 (hu) 2012-02-15 2022-09-28 Cydex Pharmaceuticals Inc Elõállítási eljárás ciklodextrin-származékokhoz
MX353603B (es) 2012-02-28 2018-01-19 Cydex Pharmaceuticals Inc Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas.
WO2014066274A1 (en) 2012-10-22 2014-05-01 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
HUE063851T2 (hu) 2014-08-22 2024-02-28 Cydex Pharmaceuticals Inc Frakcionált alkilezett ciklodextrin készítmények és eljárás ezek elõállítására és alkalmazására
CN115038723A (zh) 2019-11-18 2022-09-09 锡德克斯药物公司 烷基化环糊精组合物及其制备和使用方法
US12698348B2 (en) 2020-09-24 2026-08-04 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2051495B1 (enExample) * 1969-04-02 1974-08-30 Taiho Pharmaceutical Co Ltd
JPS5748957A (en) * 1980-09-08 1982-03-20 Microbial Chem Res Found Novel antibiotic bmg 162-af2, its preparation and carcinostatic agent comprising it as active ingredient
JPS57192347A (en) * 1981-05-18 1982-11-26 Microbial Chem Res Found N-(4-(3-aminopropyl)aminobutyl)-2,2-dihydroxyethanamide and its synthesis
JPS57185254A (en) * 1981-05-11 1982-11-15 Microbial Chem Res Found Novel carcinostatic substances and their preparation
JPS5862152A (ja) * 1981-10-08 1983-04-13 Microbial Chem Res Found Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
US4525299A (en) * 1983-05-10 1985-06-25 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (-)-15-Deoxyspergualin, process for the preparation thereof, and intermediate of the same

Also Published As

Publication number Publication date
ES8402558A1 (es) 1984-02-01
AU554489B2 (en) 1986-08-21
JPS5862152A (ja) 1983-04-13
CS717982A2 (en) 1989-08-14
CH653015A5 (de) 1985-12-13
JPS6123183B2 (enExample) 1986-06-04
HU187417B (en) 1986-01-28
CS268654B2 (en) 1990-04-11
US4658058A (en) 1987-04-14
SE8205698L (sv) 1983-04-09
SE452006B (sv) 1987-11-09
DK445182A (da) 1983-04-09
YU227682A (en) 1985-06-30
CA1187513A (en) 1985-05-21
AU8912182A (en) 1983-04-14
SE8205698D0 (sv) 1982-10-06
GB2111480B (en) 1985-03-13
IT1189373B (it) 1988-02-04
ES526501A0 (es) 1985-04-16
FR2514350A1 (fr) 1983-04-15
BE894651A (fr) 1983-01-31
KR840001952A (ko) 1984-06-07
NL193107B (nl) 1998-07-01
AT393680B (de) 1991-11-25
DE3236725C2 (enExample) 1991-01-24
GB2111480A (en) 1983-07-06
ES8504690A1 (es) 1985-04-16
NL8203874A (nl) 1983-05-02
NL193107C (nl) 1998-11-03
US4518532A (en) 1985-05-21
DE3236725A1 (de) 1983-04-28
YU44678B (en) 1990-12-31
US4983328A (en) 1991-01-08
ES516258A0 (es) 1984-02-01
DK166080B (da) 1993-03-08
ATA369682A (de) 1991-05-15
DK166080C (da) 1993-08-02
IT8249228A0 (it) 1982-10-07
KR870000656B1 (ko) 1987-04-04

Similar Documents

Publication Publication Date Title
BE894651A (fr) "n-(3-aminopropyl) aminobutyl)-2-(-guanidino(acido gras) amido) - thanamides substitues en position 2 et leur sels, procede pour leur preparation et leur application therapeutique
LU84486A1 (fr) Nouveau derive de l'acide 2-(p-isobutylphenyl)propionique,son procede de preparation et son application en therapeutique
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
FR2525223B1 (fr) Nouveaux acides diphosphoniques, leurs sels, leur procede de preparation et leur application en therapeutique
BE887574R (fr) Derives de l'acide quinoleine-carboxylique et procede pour leur preparation
BE864112A (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
FR2347330A1 (fr) Procede de preparation d'acide methacrylique et de methacrylate de methyle
BE881631A (fr) Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
BE882764A (fr) Derives d'acide peneme-3-carboxylique, leurs procedes de preparation et leur application en therapeutique
FR2502626B1 (fr) Acides oxazaphosphorin-4-thio-alcanesulfoniques, leurs sels neutres, procede pour leur preparation et preparations pharmaceutiques qui les contiennent
FR2496106B1 (fr) Derives d'acide 7-acylaminocephalosporanique et procede pour leur preparation
FR2312243A1 (fr) Nouvelles propargyl-2-phenylamino-imidazolines-(2), leurs sels d'addition avec des acides, les medicaments les renfermant et procedes pour leur preparation
FR2517670B1 (fr) Sel d'acide (+)-2-(2-fluoro-4-biphenylyl)propionique, procede pour sa preparation et composition pharmaceutique le contenant
FR2348226A1 (fr) Procede de preparation d'acides steroidecarboxyliques et de leurs esters
FR2321888A1 (fr) N-tetrahydrofurfuryl-noroxymorphones, leurs sels d'addition avec des acides, procedes pour leur preparation et medicaments en renfermant
FR2510583B1 (fr) Derives nouveaux d'acide ursodesoxycholique, leur procede de preparation et leur application en therapeutique
PT77214A (fr) Nouveaux derives d'amino-14 steroides procede pour leur preparation et application en therapeutique
PT75949B (fr) Procede pour la preparation de derives d'acides amines en n-(vinblastinoil-23)
FR2525221B1 (fr) Derives du furanne et sels d'addition de ces derives, leurs procedes de preparation et leurs applications en therapeutique
BE826536A (fr) Procede de preparation d'acide methacrylique et de butyrolactone
LU80811A1 (fr) Derives d'acide naphtyl-l acetique,leur procede de preparation et leur application therapeutique
BE889699A (fr) Derives amidiques de l'acide p-isobutylphenyl propionique, leur procede de preparation et compositions pharmaceutiques correspondantes
FR2531704B1 (fr) Amides d'acides (hetero)aromatiques n-substitues, leurs sels, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2304605A1 (fr) Nouveaux acides amidosulfocarboxyliques et leurs sels, leur procede de preparation et leur utilisation notamment comme agents protecteurs anticorrosion
BE837860A (fr) Derives d'acide glycyrrhetinique et procede pour leur preparation